Skip to main content
Print Save

Kisqali Prices, Coupons and Patient Assistance Programs

Kisqali (ribociclib) is a member of the CDK 4/6 inhibitors drug class and is commonly used for Breast Cancer, and Breast Cancer - Metastatic.

Kisqali Prices

The cost for Kisqali oral tablet 200 mg is around $5,927 for a supply of 21 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Kisqali is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Kisqali availability.

This Kisqali price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Oral Tablet

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Kisqali Coupons and Rebates

Kisqali offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Kisqali Novartis Universal Co-Pay Card: Eligible commercially insured patients may pay no more than $25 for each prescription with a maximum savings of $15,000 per calendar year; for additional information contact the program at 877-577-7756.

Applies to:
Kisqali
Number of uses:
per prescription per calendar year

Form more information phone: 877-577-7756 or Visit website

Kisqali 1 Free Treatment Cycle: Eligible patients may receive a 1-treatment cycle supply for free; for additional information contact the program at 800-282-7630.

Applies to:
Kisqali
Number of uses:
One-time offer

Form more information phone: 800-282-7630 or Visit website

Kisqali Femara Co-Pack 1 Free Treatment Cycle: Eligible patients may receive a 1-treatment cycle supply for free; for additional information contact the program at 800-282-7630.

Applies to:
Kisqali and Femara
Number of uses:
One-time offer

Form more information phone: 800-282-7630 or Visit website

Kisqali & Femara Novartis Universal Co-Pay Card: Eligible patients may pay no more than $25 for each of your prescriptions with a maximum savings of $15,000 per year; for additional information contact the program at 877-577-7756.

Applies to:
Kisqali and Femara
Number of uses:
per prescription per calendar year

Form more information phone: 877-577-7756 or Visit website

Kisqali 5-Treatment Cycle Access: Eligible commercially insured patients who are still waiting for coverage may obtain an additional 5 treatment supply; for additional information contact the program at 800-282-7630.

Applies to:
Kisqali
Number of uses:
Temporary Assistance

Form more information phone: 800-282-7630 or Visit website

Kisqali Femara 5-Treatment Cycle Access: Eligible commercially insured patients who are still waiting for coverage may obtain an additional 5 treatment supply; for additional information contact the program at 800-282-7630.

Applies to:
Kisqali and Femara
Number of uses:
Temporary Assistance

Form more information phone: 800-282-7630 or Visit website

Patient Assistance Programs for Kisqali

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Novartis Patient Assistance Foundation, Inc. (NPAF)

Elligibility requirements:
  1. Contact program for details.
  2. At or below 600% of FPL
  3. Not specified
  4. The patient must reside in the US, Puerto Rico or the USVI.
  5. For Focalin XR, Clozaril, and Ritalin LA, Clozarila pharmacy card will be issued. All other medication will be shipped directly to the patient, unless otherwise noted. *Additional products may be available. Please contact the program for a complete product listing. www.pap.novartis.com
Applicable drugs:
  • Kisqali (ribociclib) Tablet
  • Kisqali and Femara (ribociclib and letrozole) Tablet; Co-Pack

More information please phone: 800-277-2254 Visit Website

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Kisqali (ribociclib) Tablet
  • Kisqali and Femara (ribociclib and letrozole) Tablet; Co-Pack

More information please phone: 866-316-7263 Visit Website

Provider: PANO (Novartis Patient Assistance Now Oncology)

Elligibility requirements:
  1. Determined case by case
  2. Not applicable
  3. Not specified
  4. The patient must reside in the US, Puerto Rico or the USVI.
  5. Eligibility determined on a case-by-case basis. Co-payment assistance, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Kisqali (ribociclib) Tablet
  • Kisqali and Femara (ribociclib and letrozole) Tablet; Co-Pack

More information please phone: 800-282-7630 Visit Website